基本信息
浏览量:39
职业迁徙
个人简介
Dr. Singh is a cancer immunobiologist and nanotechnologist and his laboratory use both in silico and in vivo methods to develop vaccines, and nanoparticles to diagnose, prevent, and/or treat (prostate, breast, pancreatic, lung and ovarian) cancers. He is authored more than 192 scientific communications, including patent applications, meeting abstracts, and peer-reviewed publications. His work has been nationally and internationally recognized as indicated by appointments on editorial boards and scientific reviewers for the study sections. His laboratory is focused on to develop therapeutic and chemo-preventive strategies for cancer using targeted delivery of natural and synthetic agents. His long-term goal is to improve the therapeutic outcome and overall survival of cancer patients.
研究兴趣
论文共 409 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
LETTERS IN DRUG DESIGN & DISCOVERYno. 5 (2024): 961-978
Sumanta Sahoo,Rajesh Kumar,Iftikhar Hussain, Rajiv Kumar Verma, Thanayut Kaewmaraya, Tanveer Hussian,Sung Soo Han
Carbon (2024): 119537
Journal of traditional and complementary medicineno. 5 (2024): 494-500
Cancer letters (2024): 216710-216710
Rajesh Singh, Anamika Kumari
Brazilian Journal of Biometricsno. 3 (2024): 272-288
Murugesh Eswaran, Briana A, Hina Abdulrehman Mir, Eric L. Flenaugh,Oprea M. Gabriela, Brian Rivers,Rajesh Singh, Shailesh Singh
Cancer Epidemiology, Biomarkers & Preventionno. 9_Supplement (2024)
Cancersno. 12 (2024)
加载更多
作者统计
#Papers: 470
#Citation: 20571
H-Index: 72
G-Index: 132
Sociability: 6
Diversity: 4
Activity: 341
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn